During the January, 2025 Zoom Support Meeting, the group saw a presentation about Zilucoplan, a drug that was approved by the FDA in October 2023. It is manufactured by UCB Pharmaceutical
Zilucoplan is for adults with gMG who are anti-acetylcholine receptor (ACjR) antibody positive. It can be self=administered via once-daily subcutaneous injection.
If you would like more information, please contact your health professional.